96701 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
#2FLUORESCENT PROBE FOR USE IN DETECTION OF PANCREATIC CANCER
#3TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
#4COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF THE ANDROGEN RECEPTOR
#5LINKER COMPOUNDS COMPRISING AMIDE BONDS
#6Bioactive Collagen Peptides, Method Of Production Thereof, And Use Thereof
#7COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#8Compositions and methods for treating and preventing neurodegenerative disorders
#9Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#10Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#11DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF
#12CSF1R-BASED CHIMERIC PROTEINS
#13Functionalized peptides as antiviral agents
#14FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS
#15COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#16Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#17Preparation and uses of reactive oxygen species scavenger derivatives
#18Compositions and methods for treating and preventing neurodegenerative disorders
#19Pro-pigmenting peptides
#20N-acyldipeptide derivatives and their uses
#21Preparation and uses of reactive oxygen species scavenger derivatives
#22CSF1R-based chimeric proteins
#23COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#24CSF1R-CD40L chimeric proteins
#25PROCESS FOR PREPARATION OF ICATIBANT ACETATE
#26CSF1R-based chimeric proteins
#27N-lipoic-amino acid or peptide, derivatives and their uses
#28Pro-pigmenting peptides
#29NDMA RECEPTOR MODULATORS AND USES THEREOF
#30Alpha-Ketoamide Inhibitors Of Cysteine Proteases
#31Carbonic anhydrase IX inhibitor conjugates and uses thereof
#32Molecular gelators and uses thereof
#33COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#34Method for manufacturing a metal nanostructure having a chiral structure comprising regioselectivity adsorbing a peptide on the surface of a metal seed particle
#35Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof
#36NMDA RECEPTOR MODULATORS AND USES THEREOF
#37Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#38Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#39Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging
#40Desacetoxytubulysin H and analogs thereof
#41TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
#42Pyrrolobenzodiazepines and conjugates thereof
#43Compositions and methods for treating colorectal cancer
#44N-acyldipeptide derivatives and their uses
#45Pro-pigmenting peptides
#46Myoblast differentiation promoter
#47Branched chain-containing aromatic compound
#48Dimeric IAP inhibitors
#49Tubulysin compounds, methods of making and use
#50HCV protease inhibitors and uses thereof
#51Compounds and methods for the targeted degradation of androgen receptor
#52Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof
#534-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#54Dimeric IAP Inhibitors
#55MYOBLAST DIFFERENTIATION PROMOTER
#56Polymers, pharmaceutical compositions and methods of synthesizing the same
#57Pro-pigmenting peptides
#58N-acyldipeptide derivatives and their uses
#59SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS
#60Aldehyde capture ligation technology for synthesis of amide bonds
#61HCV protease inhibitors and uses thereof
#62Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#63Acyl dipeptide derivative
#64Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates
#65Tubulysin compounds, methods of making and use
#66THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#67Niacin-peptide having skin whitening activity and use for same
#68THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#69Organic compounds and their uses
#704-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#71HCV protease inhibitors and uses thereof
#72DPP-4 inhibitor
#73N-acyldipeptide derivatives and their uses
#74Process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
#75Tubulysin compounds, methods of making and use
#76Tubulysin compounds, methods of making and use
#77Neuroprotective and neurorestorative methods and compositions
#78Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#79HCV protease inhibitors and uses thereof
#80Selective inhibitors of prolylcarboxypeptidase
#81Process for making HCV protease inhibitors
#825,5-fused arylene or heteroarylene hepatitis C virus inhibitors
#83NMDA receptors modulators and uses thereof
#84Peptidomimetic sulfamide compounds and antiviral uses thereof
#85Peptidomimetic sulfamide compounds and antiviral uses thereof
#86HCV protease inhibitors and uses thereof
#87Hemiasterlin derivatives and uses thereof in the treatment of cancer
#88Collagen peptide, dipeptide and malady inhibitor
#89Native chemical ligation at serine and threonine sites
#90Organic compounds and their uses
#91HCV protease inhibitors and uses thereof
#92Branched chain-containing aromatic compound
#93COLLAGEN PEPTIDE COMPOSITION HAVING GOOD ABILITY TO ENTER THE BLOOD AND FOOD OR BEVERAGE CONTAINING THE SAME
#94Neuroprotective and neurorestorative method and compositions
#95ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS
#96Dimeric IAP inhibitors
#97Dipeptoid prodrugs and the use thereof
#98Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
#99IAP BINDING COMPOUNDS
#100COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
#101Angiotensin converting enzyme inhibitory peptide
#102Collagen peptide, dipeptide and malady inhibitor
#1035,5-fused arylene or heteroarylene hepatitis C virus inhibitors
#104Macrocyclic peptides as inhibitors of viral replication
#105Organic compounds and their uses
#106Derivatised proline containing peptide compounds as protease inhibitors
#107Macrocyclic inhibitors of hepatitis C virus
#108Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
#109Inhibitors of integrin alpha2beta1 based on prolyl diaminopropionic acid scaffold
#110ANTIVIRAL COMPOUNDS
#1114-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
#112Pyrimidine substituted macrocyclic HCV inhibitors
#113Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#114Dimeric IAP inhibitors
#115HCV protease inhibitors and uses thereof
#116Hemiasterlin derivatives and uses thereof in the treatment of cancer
#117TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY
#118SYNTHESIS OF DESACETOXYTUBULYSIN H AND ANALOGS THEREOF
#119HCV protease inhibitors and uses thereof
#120HCV protease inhibitors and uses thereof
#121Peptides directed for diagnosis and treatment of amyloid-associated diseases
#122HCV protease inhibitors and uses thereof
#123AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF
#124Inhibitors of the α2β1/GPIa-IIa integrin
#125COMPOUNDS FOR ENZYME INHIBITION
#126Inhibitors of integrin alpha2beta1 with modified urea moiety
#127Triazole-containing macrocyclic HCV serine protease inhibitors
#128Macrocyclic oximyl hepatitis C serine protease inhibitors
#129Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease
#130Quinoxalinyl derivatives
#131HCV protease inhibitors and uses thereof
#132C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors
#133Prodrugs of carbamate inhibitors of IMPDH
#134Urea-containing peptides as inhibitors of viral replication
#1354-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#136OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS
#137AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS
#138Quinoxalinyl dipeptide hepatitis C virus inhibitors
#139Amino acid derivatives and pharmaceutical uses thereof
#140Macrocyclic inhibitors of hepatitis C virus
#141Process for preparing macrocyclic compounds
#142Selective inhibitors of neurotensin degrading enzymes
#143Hemiasterlin derivatives and uses thereof in the treatment of cancer
#144Organic compounds and their uses
#145Compounds and compositions as channel activating protease inhibitors
#146Organic Compounds and Their Uses
#147Multi-location tractor trailer pneumatic connections
#148Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
#149Cell adhesion inhibitors
#150Dipeptide phenyl ethers
#151Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#152Aza-peptide macrocyclic hepatitis c serine protease inhibitors
#153Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
#154Peptides directed for diagnosis and treatment of amyloid-associated disease
#155Dimeric IAP inhibitors
#156Cell adhesion inhibitors
#1572-hydroxytetrahydrofuran derivatives and use thereof as medicaments
#158Flexible method and apparatus for high throughput production and purification of multiple proteins
#159Amino acid derived prodrugs of propofol, compositions and uses thereof
#160Compounds for enzyme inhibition
#161Synthetic glyco-lipo-peptides as vaccines
#162Cell adhesion inhibitors
#163Novel amide derivatives as growth hormone secretagogues
#164Anti-inflammatory compositions and methods
#165Hemiasterlin derivatives and uses thereof
#166Template-fixed peptidomimetics with antibacterial activity
#167New peptide derivatives
#168Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
#169Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments
#170Process for preparing macrocyclic compounds
#171Heterocyclic amides with alpha-4 integrin antagonist activity
#172Novel guanidinyl derivatives
#173Prodrugs of carbamate inhibitors of IMPDH
#174Dipeptide phenyl ethers
#175Antiarrhythmic peptides
#176Aza-peptide macrocyclic hepatitis C serine protease inhibitors
#177Isotopically coded affinity markers 3
#178Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#179ACE inhibitor derivatives